{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:32:43Z","timestamp":1773804763209,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jiac.2023.12.014","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T04:11:11Z","timestamp":1704427871000},"page":"659-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acute acalculous cholecystitis following extended administration of nirmatrelvir\/ritonavir for persistent SARS-CoV-2 infection"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3481-7957","authenticated-orcid":false,"given":"Wataru","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4910-5124","authenticated-orcid":false,"given":"Tatsuya","family":"Fukumori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2173-2492","authenticated-orcid":false,"given":"Nao","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-3498","authenticated-orcid":false,"given":"Natsuko","family":"Imakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryutaro","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4443-2377","authenticated-orcid":false,"given":"Yuji","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fujikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5151-3012","authenticated-orcid":false,"given":"Takayuki","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-4434","authenticated-orcid":false,"given":"Harutaka","family":"Katano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6431-7208","authenticated-orcid":false,"given":"Kei","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.12.014_bib1","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.12.014_bib2","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2023.12.014_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/bjh.15232","article-title":"A tale of two antibodies: obinutuzumab versus rituximab","volume":"182","author":"Freeman","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2023.12.014_bib4","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/cid\/ciab700","article-title":"Incidence, clinical presentation, relapses and outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients treated with anti-CD20 monoclonal antibodies","volume":"74","author":"Calder\u00f3n-Parra","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.12.014_bib5","doi-asserted-by":"crossref","first-page":"ofac382","DOI":"10.1093\/ofid\/ofac382","article-title":"Extended remdesivir infusion for persistent coronavirus disease 2019 infection","volume":"9","author":"Martinez","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2023.12.014_bib6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/cid\/ciac868","article-title":"Successful treatment of prolonged, severe coronavirus disease 2019 lower respiratory tract disease in a B cell acute lymphoblastic leukemia patient with an extended course of remdesivir and nirmatrelvir\/ritonavir","volume":"76","author":"Ford","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.12.014_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40164-022-00307-9","article-title":"Novel treatment combining antiviral and neutralizing antibody-based therapies with monitoring of spike-specific antibody and viral load for immunocompromised patients with persistent COVID-19 infection","volume":"11","author":"Wada","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jiac.2023.12.014_bib8","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/cid\/ciad085","article-title":"Successful combination treatment for persistent severe acute respiratory syndrome coronavirus 2 infection","volume":"76","author":"Blennow","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.12.014_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/cid\/ciac847","article-title":"Dual antiviral therapy for persistent coronavirus disease 2019 and associated organizing pneumonia in an immunocompromised host","volume":"76","author":"Trottier","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.12.014_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/cid\/ciad181","article-title":"Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed severe acute respiratory syndrome coronavirus 2 in immunocompromised patients","volume":"77","author":"Mikulska","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jiac.2023.12.014_bib12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2020.06.006","article-title":"COVID-19 and the liver","volume":"73","author":"Jothimani","year":"2020","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jiac.2023.12.014_bib13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/MEG.0000000000001817","article-title":"COVID-19 and liver injury: a meta-analysis","volume":"33","author":"Wijarnpreecha","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.jiac.2023.12.014_bib14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.livres.2021.09.001","article-title":"The clinical implication of gamma-glutamyl transpeptidase in COVID-19","volume":"5","author":"Liu","year":"2021","journal-title":"Liver Res"},{"issue":"12","key":"10.1016\/j.jiac.2023.12.014_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14933","article-title":"Gamma-glutamyl-transferase may predict COVID-19 outcomes in hospitalised patients","volume":"75","author":"Kasapoglu","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.jiac.2023.12.014_bib16","first-page":"133","article-title":"Acute acalculous cholecystitis as a rare gastroenterological association of COVID-19: a case series and systematic review","volume":"9","author":"Awan","year":"2023","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.jiac.2023.12.014_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijscr.2021.106731","article-title":"Acute acalculous cholecystitis caused by SARS-CoV-2 infection: a case report and literature review","volume":"90","author":"Futagami","year":"2022","journal-title":"Int J Surg Case Rep"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T12:56:09Z","timestamp":1716382569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1341321X24000011"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.12.014","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute acalculous cholecystitis following extended administration of nirmatrelvir\/ritonavir for persistent SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}